Jack Henry & Associates, Inc. · JKHY · FY2026 Q3 · Calendar Q2 2026
JKHY Beats on EPS and Revenue, Raises FY26 Guidance, but Shares Drop on Margin Concerns
Jack Henry posted a record fiscal Q3, beating consensus on both lines -- non-GAAP EPS of $1.71 versus $1.43 estimated (a 19.6% surprise) and revenue of $636.2M versus $619.7M estimated (a 2.7% surprise). Non-GAAP revenue reached $616M, up 7.3% YoY, with operating margin holding at 22.9%. The company raised full-year FY2026 guidance for both revenue (6.6% to 7.1% non-GAAP growth) and margin expansion. The quarter featured 17 core wins including a record number of $1B+ institutions, with 58% of wins bundling digital banking and card solutions. AI adoption accelerated, with roughly 100 approved tools supporting 500+ use cases and up to 90% coding productivity gains. Free cash flow surged 137% YoY, supporting aggressive share repurchases and a new $1B revolving credit facility. Despite the beat-and-raise, shares fell 5.7% on an abnormal basis the next session and drifted an additional…
Company context
Snapshot as of publicationJack Henry & Associates, Inc. operates as a financial technology company that connects people and financial institutions through technology solutions and payment processing services. It operates through four segments: Core, Payments, Complementary, and Corporate and Other. The Core segment provides core information processing platforms to banks and credit unions, which consist of integrated applications required to process deposit, loan, general ledger transactions, and maintain centralized accountholder information. The Payments segment offers secure payment processing tools and services, including ATM, automated clearing house origination and remote deposit capture processing, and risk management products and services, as well as debit and credit card processing services, and online and mobile bill pay solutions.…
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Outperform | Outperform | Maintain | Jun 18, 2026 |
| DA Davidson | Buy | Buy | Maintain | May 13, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | May 7, 2026 |
| Wells Fargo | Overweight | Equal Weight | Upgrade | Feb 17, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Feb 5, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jan 8, 2026 |
| UBS | Neutral | Neutral | Maintain | Jan 8, 2026 |
| Baird | Neutral | Neutral | Maintain | Dec 15, 2025 |
| Keefe, Bruyette & Woods | Outperform | Market Perform | Upgrade | Dec 8, 2025 |
| Compass Point | Buy | Neutral | Upgrade | Nov 6, 2025 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Nov 6, 2024 |
| Evercore ISI Group | In Line | In Line | Maintain | Jun 25, 2024 |
| B of A Securities | Buy | Neutral | Upgrade | Dec 6, 2023 |
| Oppenheimer | Outperform | Outperform | Maintain | Oct 18, 2023 |
| Northcoast Research | Buy | Neutral | Upgrade | Sep 18, 2023 |
| BTIG | Buy | Buy | Maintain | Aug 17, 2023 |
| William Blair | Outperform | Outperform | Maintain | Jan 11, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Aug 18, 2022 |
| Raymond James | Market Perform | Outperform | Downgrade | Dec 15, 2021 |
| Atlantic Equities | Neutral | Neutral | Maintain | Sep 3, 2019 |
| Keefe Bruyette & Woods | Perform | Market Perform | Maintain | Apr 9, 2019 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Aug 23, 2018 |
Named analyst price targets
Upside is calculated against the persisted current price $153.59. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $170 | $146.71 | +10.7% | Jul 8, 2026 |
| Wolfe Research | Analyst unavailable | $165 | $135 | +7.4% | Jun 29, 2026 |
| RBC Capital | Analyst unavailable | $173 | $124.22 | +12.6% | Jun 18, 2026 |
| Morgan Stanley | Analyst unavailable | $170 | $146.33 | +10.7% | May 8, 2026 |
| RBC Capital | Analyst unavailable | $180 | $145.51 | +17.2% | May 7, 2026 |
| UBS | Analyst unavailable | $165 | $143.95 | +7.4% | May 7, 2026 |
| Wells Fargo | Analyst unavailable | $196 | $156.76 | +27.6% | Feb 17, 2026 |
| Morgan Stanley | Analyst unavailable | $183 | $173.78 | +19.1% | Feb 5, 2026 |
| Stephens | Analyst unavailable | $205 | $173.78 | +33.5% | Feb 5, 2026 |
| Robert W. Baird | David Koning | $205 | $173.78 | +33.5% | Feb 5, 2026 |
| Wells Fargo | Analyst unavailable | $181 | $177.94 | +17.8% | Jan 30, 2026 |
| D.A. Davidson | Peter Heckmann | $216 | $178.27 | +40.6% | Jan 29, 2026 |
| Stephens | Analyst unavailable | $200 | $189.54 | +30.2% | Jan 16, 2026 |
| UBS | Analyst unavailable | $195 | $188.65 | +27.0% | Jan 8, 2026 |
| Wolfe Research | Darrin Peller | $220 | $185.97 | +43.2% | Jan 8, 2026 |
| RBC Capital | Analyst unavailable | $210 | $187.62 | +36.7% | Dec 16, 2025 |
| Robert W. Baird | Analyst unavailable | $200 | $185.8 | +30.2% | Dec 15, 2025 |
| D.A. Davidson | Peter Heckmann | $190 | $154.3 | +23.7% | Oct 29, 2025 |
| Wells Fargo | Jason Kupferberg | $161 | $156.92 | +4.8% | Oct 21, 2025 |
| Robert W. Baird | David Koning | $172 | $152.22 | +12.0% | Oct 17, 2025 |
| D.A. Davidson | Analyst unavailable | $204 | $165.56 | +32.8% | Aug 22, 2025 |
| Robert W. Baird | David Koning | $195 | $185.67 | +27.0% | Oct 17, 2024 |
| Oppenheimer | Rayna Kumar | $206 | $176.54 | +34.1% | Sep 30, 2024 |
| Robert W. Baird | David Koning | $186 | $163.75 | +21.1% | Apr 17, 2024 |
| RBC Capital | Analyst unavailable | $193 | $176.64 | +25.7% | Nov 10, 2022 |
| Morgan Stanley | Analyst unavailable | $185 | $197.43 | +20.5% | Aug 18, 2022 |
| Credit Suisse | Analyst unavailable | $180 | $197.3 | +17.2% | Aug 18, 2022 |
| RBC Capital | Analyst unavailable | $199 | $197.3 | +29.6% | Aug 18, 2022 |
| Oppenheimer | Analyst unavailable | $214 | $199.69 | +39.3% | Jul 25, 2022 |
| Morgan Stanley | Analyst unavailable | $190 | $177.11 | +23.7% | Jun 15, 2022 |
Track every rating change on JKHY the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session closeFollow JKHY with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Compared to the prior quarter, non-GAAP revenue growth accelerated from 6.7% to 7.3% YoY, while the core win count moderated from 22 to 17 -- though win quality improved, with a record number of $1B+ institutions. Operating margin contracted from 25.1% in Q2 to 22.9% in Q3. Free cash flow shifted from robust generation to a 137% YoY surge, and the company secured a new $1B revolver. AI deployment deepened, expanding from cost-reduction mentions to roughly 100 approved tools across 500+ use cases. The stablecoin initiative moved from beta testing toward commercial rollout planning pending regulatory guidance. Management scheduled an Investor Day for September 15 in Dallas.
Guidance delta
Jack Henry raised full-year FY2026 guidance for both revenue and non-GAAP margin expansion, marking the second consecutive quarter of raised guidance. Non-GAAP revenue growth is now expected at 6.6% to 7.1%, up modestly from the prior quarter's 6.4% to 7.1% range. The company did not provide explicit capex guidance in Q3, whereas the prior quarter characterized the capex outlook as stable. Free cash flow conversion was previously targeted at 90% to 100%; the Q3 print showed a 137% YoY surge, well ahead of that pace.
Key takeaways
- Record Q3 non-GAAP revenue of $616M, up 7.3% YoY, with non-GAAP EPS of $1.71 beating consensus by 19.6%
- 17 core wins including a record number of $1B+ institutions; 58% of wins bundled digital banking and card solutions
- AI adoption accelerated with roughly 100 approved tools across 500+ use cases, yielding up to 90% productivity gains in coding
- Free cash flow surged 137% YoY, supporting aggressive share repurchases and a new $1B revolving credit facility
- FY2026 guidance raised for the second consecutive quarter, with non-GAAP revenue growth now at 6.6% to 7.1%
- Despite the beat-and-raise, shares fell 5.7% on an abnormal basis and drifted an additional 8.5% lower as the market focused on Q4 margin headwinds
Management priorities
- Commercial rollout of stablecoin processing once regulatory guidance is finalized
- Full marketing launch and accelerated adoption of Tap2Local SMB merchant payment solution
- Expand Rapid Transfers to over 300 institutions
- Test and roll out a cloud-native deposit-only core platform
- Investor Day scheduled for September 15 in Dallas
- Continue cross-selling integrated trifecta solutions spanning core, digital, and card
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-31T17:21:49.410447+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-31T17:21:49.407770+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.